Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-24 Sale |
2022-05-26 5:30 pm |
ANTARES PHARMA INC. | ATRS | ROCHE ROBERT P JR Director |
167,817 | $5.6 | $939,775 | 0 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-26 5:28 pm |
ANTARES PHARMA INC. | ATRS | GUETH ANTON Director |
467,577 | $5.6 | $2,618,431 | 0 (Indirect Direct) |
View |
| 2022-05-24 Sale |
2022-05-26 5:27 pm |
ANTARES PHARMA INC. | ATRS | Richardson Peter C See Remarks |
50,613 | $5.6 | $283,433 | 0 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-26 5:26 pm |
ANTARES PHARMA INC. | ATRS | Smith Karen L. Director |
79,645 | $5.6 | $446,012 | 0 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-26 5:26 pm |
ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director |
170,575 | $5.6 | $955,220 | 0 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-26 5:25 pm |
ANTARES PHARMA INC. | ATRS | GRAHAM PETER J See Remarks |
740,843 | $5.6 | $4,148,721 | 0 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-26 5:24 pm |
ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director |
249,858 | $5.6 | $1,399,205 | 0 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-26 5:24 pm |
ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO |
915,270 | $5.6 | $5,125,512 | 0 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-26 5:23 pm |
ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President and CEO |
2,862,459 | $5.6 | $16,029,770 | 0 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-26 5:22 pm |
ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director |
79,645 | $5.6 | $446,012 | 0 (Direct) |
View |
| 2021-07-08 Sale |
2021-07-09 5:08 pm |
ANTARES PHARMA INC. | ATRS | GUETH ANTON Director |
100,000 | $4.29 | $429,000 | 467,577 (Direct) |
View |
| 2021-03-11 Sale |
2021-03-12 7:04 pm |
ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director |
50,000 | $4.28 | $214,000 | 224,406 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-03 Option Award |
2022-03-04 6:38 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO |
86,814 | $0 | 2,488,360 (Direct) |
View |
| 2022-03-03 Tax Withholding |
2022-03-04 6:38 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO |
37,695 | $3.8 | 2,488,360 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-04 6:36 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO |
27,780 | $0 | 791,036 (Direct) |
View |
| 2022-03-03 Tax Withholding |
2022-03-04 6:36 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO |
11,506 | $3.8 | 791,036 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-04 6:34 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary |
26,044 | $0 | 616,609 (Direct) |
View |
| 2022-03-03 Tax Withholding |
2022-03-04 6:34 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary |
13,635 | $3.8 | 616,609 (Direct) |
View |
| 2022-02-16 Tax Withholding |
2022-02-18 7:19 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary |
13,299 | $3.66 | 604,200 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 7:19 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary |
23,068 | $0 | 604,200 (Direct) |
View |
| 2022-02-16 Tax Withholding |
2022-02-18 7:16 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO |
11,496 | $3.66 | 774,762 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 7:16 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO |
24,606 | $0 | 774,762 (Direct) |
View |
| 2022-02-16 Tax Withholding |
2022-02-18 7:13 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO |
34,282 | $3.66 | 2,439,241 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 7:13 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO |
76,893 | $0 | 2,439,241 (Direct) |
View |
| 2021-10-26 Ownership |
2022-02-04 7:09 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director |
125,000 | $0 | 170,575 (Direct) |
View |
| 2021-10-27 Option Award |
2021-10-29 6:14 pm |
2022-10-27 2031-10-27 |
ANTARES PHARMA INC. | ATRS | Volkart Carmen B Director |
55,916 | $0 | 55,916 (Direct) |
View |
| 2021-08-27 Option Award |
2021-08-31 6:26 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director |
24,679 | $2.24 | 295,575 (Direct) |
View |
| 2021-08-27 Tax Withholding |
2021-08-31 6:26 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director |
13,820 | $4 | 295,575 (Direct) |
View |
| 2021-08-27 Exercise |
2021-08-31 6:26 pm |
2021-08-27 2021-09-08 |
ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director |
24,679 | $0 | 295,575 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:27 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | Smith Karen L. Director |
25,452 | $4.42 | 128,187 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:27 pm |
N/A 2031-06-10 |
ANTARES PHARMA INC. | ATRS | Smith Karen L. Director |
48,542 | $0 | 128,187 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:25 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | ROCHE ROBERT P JR Director |
25,452 | $4.42 | 216,359 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:25 pm |
N/A 2031-06-10 |
ANTARES PHARMA INC. | ATRS | ROCHE ROBERT P JR Director |
48,542 | $0 | 216,359 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:25 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | Richardson Peter C EVP, R&D Chief Medical Officer |
36,199 | $4.42 | 105,236 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:25 pm |
N/A 2031-06-10 |
ANTARES PHARMA INC. | ATRS | Richardson Peter C EVP, R&D Chief Medical Officer |
69,037 | $0 | 105,236 (Direct) |
View |
| 2021-06-13 Tax Withholding |
2021-06-14 6:24 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO |
29,207 | $4.45 | 925,615 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:24 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO |
85,973 | $4.42 | 925,615 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:24 pm |
N/A 2031-06-10 |
ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO |
163,963 | $0 | 925,615 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:24 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director |
31,674 | $4.42 | 345,123 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:24 pm |
N/A 2031-06-10 |
ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director |
60,407 | $0 | 345,123 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:23 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | GUETH ANTON Director |
25,452 | $4.42 | 616,119 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:23 pm |
N/A 2031-06-10 |
ANTARES PHARMA INC. | ATRS | GUETH ANTON Director |
48,542 | $0 | 616,119 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:22 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director |
25,452 | $4.42 | 128,187 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:22 pm |
N/A 2031-06-10 |
ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director |
48,542 | $0 | 128,187 (Direct) |
View |
| 2021-06-11 Tax Withholding |
2021-06-14 6:21 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary |
37,800 | $4.45 | 758,394 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:21 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary |
85,973 | $4.42 | 758,394 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:21 pm |
N/A 2031-06-10 |
ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary |
163,963 | $0 | 758,394 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:21 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director |
25,452 | $4.42 | 298,400 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:21 pm |
N/A 2031-06-10 |
ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director |
48,542 | $0 | 298,400 (Direct) |
View |
| 2021-06-11 Tax Withholding |
2021-06-14 6:20 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO |
99,209 | $4.45 | 2,871,259 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:20 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO |
248,869 | $4.42 | 2,871,259 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:20 pm |
N/A 2031-06-10 |
ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO |
474,629 | $0 | 2,871,259 (Direct) |
View |
| 2021-06-08 Tax Withholding |
2021-06-10 5:39 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO |
12,045 | $4.39 | 704,886 (Direct) |
View |
| 2021-06-08 Tax Withholding |
2021-06-10 5:38 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary |
15,996 | $4.39 | 546,258 (Direct) |
View |
| 2021-06-08 Tax Withholding |
2021-06-10 5:37 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO |
44,223 | $4.39 | 2,246,970 (Direct) |
View |
| 2021-05-04 Exercise |
2021-05-06 4:53 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | GUETH ANTON Director |
40,000 | $1.66 | 542,125 (Direct) |
View |
| 2021-05-04 Exercise |
2021-05-06 4:53 pm |
N/A 2021-05-16 |
ANTARES PHARMA INC. | ATRS | GUETH ANTON Director |
40,000 | $0 | 542,125 (Direct) |
View |
| 2021-04-29 Exercise |
2021-05-03 5:56 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | GUETH ANTON Director |
72,669 | $1.66 | 502,125 (Direct) |
View |
| 2021-04-29 Exercise |
2021-05-03 5:56 pm |
N/A 2021-05-16 |
ANTARES PHARMA INC. | ATRS | GUETH ANTON Director |
72,669 | $0 | 502,125 (Direct) |
View |
| 2021-04-26 Option Award |
2021-04-28 8:40 pm |
N/A 2031-04-26 |
ANTARES PHARMA INC. | ATRS | Richardson Peter C EVP, R&D Chief Medical Officer |
59,179 | $0 | 59,179 (Direct) |
View |
| 2021-03-11 Exercise |
2021-03-12 7:04 pm |
N/A 2026-06-02 |
ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director |
50,000 | $0 | 224,406 (Direct) |
View |
| 2021-03-11 Exercise |
2021-03-12 7:04 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director |
50,000 | $1.12 | 224,406 (Direct) |
View |